Lifecore Biomedical, Inc. Common Stock (NASDAQ: LFCR) last traded at $6.42, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Lifecore Biomedical, Inc. Common Stock’s own filings and are restated only when a new one is published.
Lifecore Biomedical, Inc. Common Stock trades on NASDAQ under the ticker LFCR. Its market capitalisation is $243.02 million.
Valuation measures for Lifecore Biomedical, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $243.02M |
|---|---|
| Enterprise value | $439.18M |
| Price / sales | 1.89 |
| Beta | 0.52 |
Trailing-twelve-month figures tagged in Lifecore Biomedical, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $128.87M |
| Net income (TTM) | -$38.72M |
|---|
| EPS (TTM) | -$1.27 |
|---|
| Gross margin | 31.27% |
|---|
| Operating margin | -13.38% |
|---|
| Cash | $17.24M |
|---|
Range and volume for LFCR over the past 52 weeks.
| 52-week high | $8.98 |
|---|---|
| 52-week low | $3.63 |
| Volume | 268.0K |
| Average volume | 307.8K |
| Previous close | $6.42 |
Invest a chosen dollar amount in Lifecore Biomedical, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LFCR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.